- BridgeBio has surpassed its interim analysis enrollment target for its Phase 3 FORTIFY study of BBP-418 in individuals living…
Durable improvements across consistent clinical domains in both adult and pediatric patients, including motor skills, communication/socialization, autonomic function, seizures, and…
ABINGDON, United Kingdom, June 18, 2024 (GLOBE NEWSWIRE) -- Emergex Vaccines Holding Limited (‘Emergex’, or the ‘Company’), a clinical-stage biotechnology company…
A clinician in consultation with a patient A clinician in discussion with a young patient Future Health Index 2024 report…
New company develops value-added medicines in the CNS space for global partneringMONTREAL and DUBAI, United Arab Emirates, June 18, 2024…
Workflow prioritization seen as biggest opportunity for automation while AI continues to gain traction; virtual care having a positive impact…
The solution, which includes the VENTANA DP 200 slide scanner, Roche's digital pathology workflow software and a display, is now…
SphingoTec and Boditech jointly introduced the kidney function biomarker Proenkephalin A 119-159 (penKid) at the 42nd AKI & CRRT course…
NEW YORK, June 17, 2024 /PRNewswire/ -- A new survey from SSCG Media Group, Omnicom Health Group's healthcare media center of…
Improved tool maximizes decision support for employees, simplifying the annual open enrollment process for organizations. NEW YORK, June 17, 2024…